NICE is set to update its guidance on treatments for Alzheimer´s disease, widening access to four drugs. The draft guidance …
MHRA approves Romvimza for tenosynovial giant cell tumour
Panthera opens clinical trial site at Keele University
Santen joins inaugural Global Summit for Eye Health as partner

